WHO's new rabies recommendations: implications for high incidence countries

Area of Science:

• Public Health
• Immunology
• Infectious Diseases

Background:

• Rabies is a fatal viral disease, preventable through timely immunization.
• The World Health Organization (WHO) periodically updates its rabies prophylaxis guidelines.
• Previous guidelines required complex and resource-intensive vaccination schedules.

Purpose of the Study:

• To summarize the revised WHO guidelines for rabies prophylaxis published in 2018.
• To discuss the scientific basis for major changes in the guidelines.
• To explore the implications of these changes for countries with high rabies incidence.

Main Methods:

• Review of the 2018 WHO guidelines for rabies prophylaxis.
• Analysis of the scientific evidence supporting guideline revisions.
• Discussion of implementation challenges and recommendations for high-burden countries.

Main Results:

• The updated WHO 2018 guidelines feature abbreviated vaccination regimens for pre- and post-exposure prophylaxis.
• These simplified regimens are cost-effective, dose-sparing, and enhance patient compliance.
• Recommendations for rabies immunoglobulin administration prioritize its use in scarcity, though further evidence is needed for specific populations.

Conclusions:

• National health authorities should adopt simplified, cost-effective rabies prophylaxis regimens based on the revised WHO guidelines.
• Implementation requires consensus building for effective public health strategies.
• Further research is needed on the safety and immunogenicity of abbreviated regimens in infants and immunocompromised individuals.